Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 2732-2736, November 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drewinko, B.
Right arrow Articles by Gottlieb, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drewinko, B.
Right arrow Articles by Gottlieb, J. A.

The Response of Synchronized Human Lymphoma Cells to Bleomycin and 1,3-Bis(2-chloroethyl)-1-nitrosourea

B. Drewinko, Barry W. Brown and J. A. Gottlieb

Departments of Clinical Chemistry and Laboratory Medicine, Biomathematic and Developmental Therapeutics, The University of Texas at Houston, M. D. Anderson Hospital and Tumor Institute, Texas Medical Center, Houston, Texas 77025

Synchronized human lymphoma cells treated with bleomycin exhibited the greatest sensitivity in G2. Doseresponse curves presented biphasic characteristics indicating the presence of sensitive and less sensitive cells in all stages of the cell cycle. Synchronized cells incubated with 1,3-bis(2-chloroethyl)-1-nitrosourea also showed the greatest sensitivity in G2. A threshold-type dose-response survival curve was elicited in all phases of the cell cycle suggesting that damage must be accumulated before cell killing is expressed even in the sensitive stages.

Received 5/11/73. Accepted 7/19/73.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.